Highlights from the New ICH Global Guideline on Drug Interaction Studies

DATE

November 8, 2022

TIME

8:00 a.m. PST, 11:00 a.m. EST, 16:00 GMT, 17:00 CET

Duration: 60 Minutes

Overview

In June 2022, the ICH released the first draft of its harmonized Drug Interaction Studies Guideline (M12). The guideline is the result of several meetings of the Expert Working Group since 2018 with the goal of harmonizing member regulatory agenciesâ€™ guidelines to create a single guideline that will be used across all member countries.

Join us to hear drug-drug interaction (DDI) experts, Drs. Brian Ogilvie and Maciej Czerwinski, discuss the differences between current in vitro DDI guidance from the relevant US FDA, EMA and PMDA guidance documents, and how to plan drug development strategies to meet the ICH M12 guideline.

Key Learning Objectives:

An understanding of the development impacts of the new ICH Drug Interaction Studies Guideline.
Differences with current FDA, EMA and PMDA DDI guidance documents.
How to plan drug development strategies to meet the ICH M12 guideline.

Who Should Attend:

Research scientists and drug development leadership aiming for successful IND / NDA submission, needing to meet regulatory requests and expectations, desiring to formulate a development plan that mitigates risks of late stage failure, or simply wanting to better understand the ADME properties and potential DDI risks of their compound.

Brought to you by:

Speakers

Brian Ogilvie, Ph.D
Vice President of Scientific Consulting
XenoTech

Maciej Czerwinski, Ph.D.
Director of Scientific Consulting
XenoTech

Jeff Huber
Contributing Editor
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Address 1*

City*

State*

Zip / Post Code*

Country*

Business Phone*

How are you involved with ADME &/or DDI evaluation? *

What are you hoping to gain from this webinar? *

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy .

View On Demand Webinars